Injectable Drugs For Type-2 Diabetes Market Share

On the basis of regional analysis, the injectable drugs for type-2 diabetes market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The North America industry is expected to dominate majority revenue share by 2036, backed by increasing prevalence of type 2 diabetes and obesity in the region.

Currently, North America region holds the maximum market share on the back of increasing prevalence of type 2 diabetes and obesity in the region along with the presence of world’s leading contributor, USA, in this field. Asian countries are expected to show significant growth owing to the initiatives taken by local government and health organizations to spread awareness about diabetes and its management using drugs and devices.